Amneal Pharmaceuticals, Inc. announced that the company has appointed Pradeep Bhadauriaas Chief Scientific Officer (CSO), effective immediately. He will succeed current CSO Dr. Shankar Hariharan, who is leaving Amneal on May 24, 2019. Pradeep joins Amneal from Apotex, Inc., where he most recently served as Executive Vice President, Global R&D, responsible for leading the company’s entire global R&D activities.